Second-tier strategies in newborn screening: potential and limitations
Newborn screening (NBS) is a public health measure to identify children with treatable disorders within the first days of life allowing presymptomatic treatment. It is the most successful measure of secondary medical prevention and part of public health programs in many countries worldwide. Applicat...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
March 14, 2022
|
| In: |
Medizinische Genetik
Year: 2022, Jahrgang: 34, Heft: 1, Pages: 21-28 |
| ISSN: | 1863-5490 |
| DOI: | 10.1515/medgen-2022-2117 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1515/medgen-2022-2117 Verlag, lizenzpflichtig, Volltext: https://www.degruyterbrill.com/document/doi/10.1515/medgen-2022-2117/html 
|
| Verfasserangaben: | Gwendolyn Gramer and Georg F. Hoffmann |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1809971470 | ||
| 003 | DE-627 | ||
| 005 | 20250530003530.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220712s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1515/medgen-2022-2117 |2 doi | |
| 035 | |a (DE-627)1809971470 | ||
| 035 | |a (DE-599)KXP1809971470 | ||
| 035 | |a (OCoLC)1341463913 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Gramer, Gwendolyn |d 1979- |e VerfasserIn |0 (DE-588)132278626 |0 (DE-627)520401697 |0 (DE-576)299048179 |4 aut | |
| 245 | 1 | 0 | |a Second-tier strategies in newborn screening |b potential and limitations |c Gwendolyn Gramer and Georg F. Hoffmann |
| 264 | 1 | |c March 14, 2022 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 12.07.2022 | ||
| 520 | |a Newborn screening (NBS) is a public health measure to identify children with treatable disorders within the first days of life allowing presymptomatic treatment. It is the most successful measure of secondary medical prevention and part of public health programs in many countries worldwide. Application of second-tier strategies in NBS allows for increased specificity and consecutively a higher positive predictive value. Second-tier strategies can include analysis of specific biomarkers for a target disorder or may be based on molecular genetic analyses. Improving the quality of NBS, for example by second-tier strategies, is of utmost importance to maintain the high acceptance of NBS by families - especially as an increasing number of target disorders is being consecutively included into NBS programs. | ||
| 650 | 4 | |a genetic screening | |
| 650 | 4 | |a metabolites | |
| 650 | 4 | |a newborn screening | |
| 650 | 4 | |a prevention | |
| 650 | 4 | |a second-tier | |
| 700 | 1 | |a Hoffmann, Georg F. |d 1957- |e VerfasserIn |0 (DE-588)115652868 |0 (DE-627)077386116 |0 (DE-576)261230042 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Medizinische Genetik |d Berlin : de Gruyter, 1998 |g 34(2022), 1, Seite 21-28 |h Online-Ressource |w (DE-627)39761571X |w (DE-600)2163157-8 |w (DE-576)265030536 |x 1863-5490 |7 nnas |a Second-tier strategies in newborn screening potential and limitations |
| 773 | 1 | 8 | |g volume:34 |g year:2022 |g number:1 |g pages:21-28 |g extent:8 |a Second-tier strategies in newborn screening potential and limitations |
| 856 | 4 | 0 | |u https://doi.org/10.1515/medgen-2022-2117 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.degruyterbrill.com/document/doi/10.1515/medgen-2022-2117/html |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20220712 | ||
| 993 | |a Article | ||
| 994 | |a 2022 | ||
| 998 | |g 115652868 |a Hoffmann, Georg F. |m 115652868:Hoffmann, Georg F. |d 910000 |d 910500 |e 910000PH115652868 |e 910500PH115652868 |k 0/910000/ |k 1/910000/910500/ |p 2 |y j | ||
| 998 | |g 132278626 |a Gramer, Gwendolyn |m 132278626:Gramer, Gwendolyn |d 910000 |d 910500 |d 50000 |e 910000PG132278626 |e 910500PG132278626 |e 50000PG132278626 |k 0/910000/ |k 1/910000/910500/ |k 0/50000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1809971470 |e 4164635541 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"type":{"bibl":"article-journal","media":"Online-Ressource"},"physDesc":[{"extent":"8 S."}],"language":["eng"],"person":[{"display":"Gramer, Gwendolyn","given":"Gwendolyn","role":"aut","family":"Gramer"},{"display":"Hoffmann, Georg F.","family":"Hoffmann","given":"Georg F.","role":"aut"}],"title":[{"subtitle":"potential and limitations","title":"Second-tier strategies in newborn screening","title_sort":"Second-tier strategies in newborn screening"}],"name":{"displayForm":["Gwendolyn Gramer and Georg F. Hoffmann"]},"recId":"1809971470","id":{"doi":["10.1515/medgen-2022-2117"],"eki":["1809971470"]},"origin":[{"dateIssuedDisp":"March 14, 2022","dateIssuedKey":"2022"}],"note":["Gesehen am 12.07.2022"],"relHost":[{"type":{"media":"Online-Ressource","bibl":"periodical"},"corporate":[{"display":"Berufsverband Medizinische Genetik","role":"isb"}],"physDesc":[{"extent":"Online-Ressource"}],"language":["ger"],"title":[{"title":"Medizinische Genetik","title_sort":"Medizinische Genetik"}],"recId":"39761571X","name":{"displayForm":["Berufsverband Medizinische Genetik e.V."]},"disp":"Second-tier strategies in newborn screening potential and limitationsMedizinische Genetik","origin":[{"dateIssuedDisp":"1998-","dateIssuedKey":"1998","publisher":"de Gruyter ; Springer","publisherPlace":"Berlin ; Berlin ; Heidelberg"}],"id":{"eki":["39761571X"],"issn":["1863-5490"],"zdb":["2163157-8"]},"note":["Gesehen am 12.04.2023"],"pubHistory":["Nachgewiesen 10.1998 -"],"part":{"year":"2022","issue":"1","pages":"21-28","volume":"34","extent":"8","text":"34(2022), 1, Seite 21-28"}}]} | ||
| SRT | |a GRAMERGWENSECONDTIER1420 | ||